INCB24360 (Epacadostat), a Highly Potent and Selective Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitor for Immuno-oncology

ACS Medicinal Chemistry Letters
Eddy W YueAndrew P Combs

Abstract

A data-centric medicinal chemistry approach led to the invention of a potent and selective IDO1 inhibitor 4f, INCB24360 (epacadostat). The molecular structure of INCB24360 contains several previously unknown or underutilized functional groups in drug substances, including a hydroxyamidine, furazan, bromide, and sulfamide. These moieties taken together in a single structure afford a compound that falls outside of "drug-like" space. Nevertheless, the in vitro ADME data is consistent with the good cell permeability and oral bioavailability observed in all species (rat, dog, monkey) tested. The extensive intramolecular hydrogen bonding observed in the small molecule crystal structure of 4f is believed to significantly contribute to the observed permeability and PK. Epacadostat in combination with anti-PD1 mAb pembrolizumab is currently being studied in a phase 3 clinical trial in patients with unresectable or metastatic melanoma.

References

May 31, 2002·Journal of Medicinal Chemistry·Daniel F VeberKenneth D Kopple
Jan 15, 2004·Trends in Molecular Medicine·David H Munn, Andrew L Mellor
Mar 25, 2005·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·A K FröhlichB Clement
Sep 24, 2005·Biochemical and Biophysical Research Communications·Osamu Takikawa
Oct 4, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Xiufen ZhengWei-Ping Min
May 4, 2007·The Journal of Clinical Investigation·David H Munn, Andrew L Mellor
Feb 20, 2008·The International Journal of Biochemistry & Cell Biology·Helen J BallNicholas H Hunt
Dec 23, 2009·Current Cancer Drug Targets·X LiuP A Scherle
Jun 8, 2010·The New England Journal of Medicine·F Stephen HodiWalter J Urba
Jul 20, 2010·Cancer Immunology, Immunotherapy : CII·Alexander J MullerGeorge C Prendergast
Feb 7, 2012·Proceedings of the National Academy of Sciences of the United States of America·Luc PilotteBenoît J Van den Eynde
Jun 12, 2013·The Journal of Experimental Medicine·Rikke B HolmgaardJames P Allison
Feb 1, 2014·Nature Reviews. Drug Discovery·Andrew L HopkinsCharles H Reynolds
Oct 25, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Scott J AntoniaPaolo A Ascierto
Dec 6, 2014·Frontiers in Immunology·George C PrendergastLaura Mandik-Nayak
Apr 22, 2015·The New England Journal of Medicine·Caroline RobertUNKNOWN KEYNOTE-006 investigators
Jun 2, 2015·The New England Journal of Medicine·James LarkinJedd D Wolchok
Jul 25, 2015·Nature Reviews. Cancer·Ignacio MeleroJohn Haanen
Aug 1, 2015·Nature Reviews. Drug Discovery·Jerry L AdamsAxel Hoos

❮ Previous
Next ❯

Citations

Nov 10, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Dong-Ho LeeJong Yeon Hwang
Dec 15, 2017·Chembiochem : a European Journal of Chemical Biology·Julie Anne Christine AlexandreJames Westcott
Nov 24, 2017·Nature Communications·Ariel Lewis-BallesterSyun-Ru Yeh
Sep 15, 2018·Journal of Drug Targeting·Yuandi ZhaoHongmin Liu
Oct 30, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Charles G Drake, Mark N Stein
Dec 7, 2018·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Wenyan WangJingwei Tian
Apr 24, 2019·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Yan ZhangSwamy Yeleswaram
Aug 3, 2018·Journal of Hematology & Oncology·Ming LiuYong Li
Feb 29, 2020·Cancer Immunology, Immunotherapy : CII·Malgorzata WachowskaAngelika Muchowicz
Mar 27, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Chuan ZhouZhiqiang Feng
Sep 12, 2020·Chemical Biology & Drug Design·Bin SunYuwei Wang
May 29, 2018·British Journal of Cancer·Lironne WeinSherene Loi
Jun 28, 2018·Frontiers in Oncology·Hildur HelgadottirAda Girnita
Jul 13, 2020·Cellular and Molecular Life Sciences : CMLS·Fang WeiZhaoyang Zeng
Feb 24, 2018·Expert Opinion on Therapeutic Patents·Jae Eun CheongLijun Sun
May 16, 2017·MedChemComm·Alice ColettiAntonio Macchiarulo
Mar 21, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Hongchuan ZhaoChunyong Ding
Aug 17, 2019·Frontiers in Immunology·Juliane GüntherElisa Wirthgen
Oct 23, 2019·Signal Transduction and Targeted Therapy·Heng LiangQing Yang
Mar 28, 2019·Nature Reviews. Clinical Oncology·Xiaoyun LiPing-Chih Ho
Aug 23, 2020·Cells·Nefertiti MuhammadJiyeon Kim
Sep 12, 2018·Seminars in Immunopathology·Alexander J MullerGeorge C Prendergast
May 30, 2020·Journal of Enzyme Inhibition and Medicinal Chemistry·Shushan GeYisheng Lai
Jun 21, 2019·Medicinal Research Reviews·Daniela TomaselliAntonello Mai
Oct 12, 2020·Neurochemical Research·Micheli Stéfani ZarzeckiCristiano Ricardo Jesse
Oct 27, 2020·Frontiers in Pharmacology·Long-Fei MaoYue-Ming Li
Sep 26, 2020·Chembiochem : a European Journal of Chemical Biology·Rodrigo F Ortiz-MeozGuofeng Zhang
Dec 7, 2019·Cancer Immunology Research·Florence SchrammeBenoit J Van den Eynde
Mar 5, 2020·Cancer Immunology Research·Baosheng ChenMatthew A Ciorba
Jun 28, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Eric C KoSilvia C Formenti
Dec 17, 2017·Cancer Research·George C PrendergastAlexander J Muller
Dec 15, 2020·Bioorganic & Medicinal Chemistry Letters·Olaf KinzelThomas Hoffmann

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.